MONEY

ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 19, 2024 - 20:00
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
Read More

Tags:

Previous Article

Join Mobilicom's Exclusive Live Investor Webinar and Q&A Session on September 25

Next Article

Girard Sharp LLP and The Hall Firm, Ltd. Attorneys File Securities Class Action ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

HP Imagine 2024: Innovating for the Future of Work

HP Imagine 2024: Innovating for the Future of Work

Tomas Kauer - Mode... Sep 13, 2024

US locks in steep China tariff hikes, some industries warn of disruptions

US locks in steep China tariff hikes, some industries w...

Tomas Kauer - Mode... Sep 14, 2024

United Airlines taps Elon Musk's Starlink for in-flight internet

United Airlines taps Elon Musk's Starlink for in-flight...

Tomas Kauer - Mode... Sep 14, 2024